Niessen, Frank <br/><br/>
Differences in clot preparation determine outcome of recombinant tissue plasminogen activator treatment in experimental thromboembolic stroke.  [electronic resource] 

 -  Stroke  Aug 2003 
 - 2019-24 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1524-4628 
<br/><br/><label>Standard No.: </label>10.1161/01.STR.0000080941.73934.30  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenosine Triphosphate--metabolism<br/>Animals<br/>Blood-Brain Barrier--drug effects<br/>Brain--blood supply<br/>Cerebral Hemorrhage--etiology<br/>Cerebrovascular Circulation--drug effects<br/>Disease Models, Animal<br/>Disease Progression<br/>Elasticity<br/>Extravasation of Diagnostic and Therapeutic Materials<br/>Fibrin--administration & dosage<br/>Gadolinium DTPA<br/>Infarction, Middle Cerebral Artery--complications<br/>Intracranial Thrombosis--complications<br/>Magnetic Resonance Angiography<br/>Male<br/>Rats<br/>Rats, Wistar<br/>Recombinant Proteins--adverse effects<br/>Reperfusion--methods<br/>Stroke--complications<br/>Thrombin<br/>Thrombolytic Therapy--methods<br/>Time Factors<br/>Tissue Plasminogen Activator--adverse effects<br/>Treatment Outcome